...
机译:IV阶段ROS1 -RALANRANGED非小细胞肺癌的脑转移发病率和颅骨中枢神经系统进展的速率
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Department of Pediatrics Cancer Center Biostatistics Core University of Colorado and Children's;
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Department of Pathology University of Colorado School of Medicine;
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Department of Medicine Division of Medical Oncology University of Colorado School of Medicine;
Brain metastasis; Non–small cell lung cancer; Crizotinib; ROS1;
机译:IV阶段ROS1 -RALANRANGED非小细胞肺癌的脑转移发病率和颅骨中枢神经系统进展的速率
机译:IV期非小细胞肺癌中ROS1重排和对克唑替尼的反应
机译:治疗中枢神经系统转移在屈服治疗过程中晚期血糖淋巴瘤激酶重排非小细胞肺癌的管理
机译:放射组学诺模图的开发和验证,用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
机译:晚期(IIIB和IV)非小细胞肺癌患者症状管理的评估
机译:克唑替尼治疗IV期ROS1重排的非小细胞肺癌的脑转移发生率和中枢神经系统进展的速度。
机译:孤立性中枢神经系统进展后继续克唑替尼给药对ALK重排阳性的肺癌患者的临床影响